Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers

Fig. 3

Kaplan–Meier analysis of patient overall survival according to cytoplasmic PPARγ and of Cox-1 expression in subgroups. Overall survival (OS) curves are presented according to cytoplasmic PPARγ status in Cox-1 (a, b) and Cox-2 (c, d) subgroups. OS of Cox-1 is then presented according to cytoplasmic PPARγ (e, f). The IRS cut-off values with the number of cases for each group are indicated in each graph. Statistical significance is shown as p-value from log-rank test (*p < 0.05; **p < 0.01)

Back to article page